| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-07 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-05 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-05 |